Sapreme Technologies - Crunchbase Company Profile & Funding

Q: How much funding has Sapreme Technologies raised to date?

Sapreme Technologies has raised obfuscated.

Overview

Sapreme Technologies

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Sapreme Technologies

CB Rank

51500

Sapreme Technologies is a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutic.

Founded

obfuscation

Private

Series A

Bilthoven, Utrecht, The Netherlands

11-50

sapreme-technologies.com/

Biotechnology

Life Science

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Key People

Guy Hermans: Chief Executive Officer
Past Role: Isogenica, Chief Science Officer
Ruben Postel: CSO & Scientific Founder

Details

Legal Name

Sapreme Technologies BV

Operating Status

Active

Company Type

For Profit

Founders

Ruben Postel

About the Company

Sapreme Technologies is a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutic.

Predictions & Insights

Growth Insight

See this Growth Insight

Sapreme Technologies is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Proprietary Endosomal Escape Technology Platform (SPT)

A technology platform that enhances intracellular delivery of large molecule therapeutics by enabling endosomal escape, improving access to intracellular targets in various tissues.

Next-Generation RNA Therapeutics Pipeline

A pipeline of RNA-based therapeutic candidates utilizing the endosomal escape platform to treat genetically driven diseases, including a lead program for Duchenne muscular dystrophy.

Research & Development

Sapreme Technologies is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A
obfuscated obfuscation	Series A - Sapreme Technologies	1	obfuscated obfuscation	Aglaia BioMedical Ventures	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Aglaia BioMedical Ventures	Yes	Series A - Sapreme Technologies	—
Aglaia BioMedical Ventures	Yes	Series A - Sapreme Technologies	—
Aglaia BioMedical Ventures	Yes	Series A - Sapreme Technologies	—
Aglaia BioMedical Ventures	Yes	Series A - Sapreme Technologies	—
Aglaia BioMedical Ventures	Yes	Series A - Sapreme Technologies	—